Zymeworks Inc.
ZYME
$23.90
-$0.13-0.54%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 81.26M | 105.97M | 134.48M | 122.87M | 93.38M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 81.26M | 105.97M | 134.48M | 122.87M | 93.38M |
| Cost of Revenue | 135.72M | 137.00M | 142.83M | 143.60M | 139.50M |
| Gross Profit | -54.46M | -31.04M | -8.35M | -20.74M | -46.11M |
| SG&A Expenses | 59.60M | 61.51M | 62.27M | 61.97M | 62.70M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 195.32M | 198.51M | 205.10M | 205.58M | 202.20M |
| Operating Income | -114.05M | -92.55M | -70.61M | -82.71M | -108.81M |
| Income Before Tax | -103.97M | -79.75M | -56.07M | -67.42M | -107.17M |
| Income Tax Expenses | -1.31M | 1.38M | 7.36M | 6.25M | 6.51M |
| Earnings from Continuing Operations | -102.66 | -81.13 | -63.43 | -73.68 | -113.68 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -102.66M | -81.13M | -63.43M | -73.68M | -113.68M |
| EBIT | -114.05M | -92.55M | -70.61M | -82.71M | -108.81M |
| EBITDA | -107.79M | -84.82M | -60.97M | -72.61M | -99.29M |
| EPS Basic | -1.37 | -1.08 | -0.84 | -0.98 | -1.50 |
| Normalized Basic EPS | -0.87 | -0.66 | -0.47 | -0.56 | -0.75 |
| EPS Diluted | -1.37 | -1.08 | -0.85 | -0.98 | -1.50 |
| Normalized Diluted EPS | -0.87 | -0.66 | -0.47 | -0.56 | -0.75 |
| Average Basic Shares Outstanding | 301.11M | 301.61M | 300.94M | 301.30M | 302.35M |
| Average Diluted Shares Outstanding | 303.19M | 303.72M | 303.10M | 303.48M | 302.50M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |